202 related articles for article (PubMed ID: 37782654)
1. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022.
Hsu JY; Hung CC; Tsou TP; Chen WC
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011421. PubMed ID: 37782654
[TBL] [Abstract][Full Text] [Related]
2. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
[TBL] [Abstract][Full Text] [Related]
4. Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
Bouckenooghe A; Bailleux F; Feroldi E
Hum Vaccin Immunother; 2019; 15(1):72-79. PubMed ID: 30230947
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
[TBL] [Abstract][Full Text] [Related]
8. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
9. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
10. Immune response at 12-23 months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Krow-Lucal ER; Laven J; Perry L; Biggerstaff BJ; Johnson BW; Hollis E; Fischer M; Woolpert T; Hills SL
Vaccine; 2020 Oct; 38(44):6899-6903. PubMed ID: 32907756
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
Kim DS; Jang GC; Cha SH; Choi SH; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Bang J; Naimi Z; Bouckenooghe A; Bosch-Castells V; Houillon G
Pediatr Infect Dis J; 2016 Feb; 35(2):e60-4. PubMed ID: 26535878
[TBL] [Abstract][Full Text] [Related]
12. The incidence of Japanese encephalitis in Taiwan--a population-based study.
Hsu LC; Chen YJ; Hsu FK; Huang JH; Chang CM; Chou P; Lin IF; Chang FY
PLoS Negl Trop Dis; 2014 Jul; 8(7):e3030. PubMed ID: 25058573
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological Features of Japanese Encephalitis in Taiwan from 2000 to 2014.
Chang YK; Chang HL; Wu HS; Chen KT
Am J Trop Med Hyg; 2017 Feb; 96(2):382-388. PubMed ID: 27821699
[TBL] [Abstract][Full Text] [Related]
14. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
[TBL] [Abstract][Full Text] [Related]
15. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
Upreti SR; Lindsey NP; Bohara R; Choudhary GR; Shakya S; Gautam M; Giri JN; Fischer M; Hills SL
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005866. PubMed ID: 28934197
[TBL] [Abstract][Full Text] [Related]
16. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study.
Vu TD; Nguyen QD; Tran HTA; Bosch-Castells V; Zocchetti C; Houillon G
Int J Infect Dis; 2018 Jan; 66():137-142. PubMed ID: 29081368
[TBL] [Abstract][Full Text] [Related]
19. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
[TBL] [Abstract][Full Text] [Related]
20. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]